Thumbay Moideen receivesGlobal Leader' honor at NDTV Gulf Indian Excellence Awards 2016

[email protected] (CD Network)
December 13, 2016

Dubai, Dec 13: To celebrate remarkable contribution in healthcare and education services across UAE, NDTV honored Mr. Thumbay Moideen, the founder president of Thumbay Group the title of “Global Leader” at the Gulf Indian Excellence Awards on Sunday, 11th December 2016. The award was presented at a gala function held at Hyatt Regency, Dubai Creek Heights, attended by leading Indian businessmen and professionals from the Gulf region.

thmby 2

Mr. Moideen was accorded the prestigious recognition for his accomplishments as an Indian entrepreneur in the Gulf region that has pioneered the transformation of education and healthcare business into a multi-disciplinary conglomerate with global presence, operating over 20 brands spread across 18 sectors.

Receiving the award, Mr. Moideen said, “I am humbled to receive this recognition. It is a great feeling when your accomplishments are recognized at global forums. Moreover, this award comes at a time when we are expanding our businesses in India, in a big way.”

Mr. Moideen also led the panel discussion on the topic “Time to Bridge the Gulf,” conducted as part of the awards ceremony. The discussion touched upon the various subjects where the UAE and India share a common interest, and explored ways to convert mutual relations into a strategic partnership. The other participants included Mr. Vicky Kapoor (Associate Editor – Khaleej Times), Mr. Shaji Ul Mulk (Chairman – Mulk Holdings) and Mr. Kulwant Singh (President – IBPC). A second panel discussion led by Dr. B. R. Shetty, Chairman – NMC Group had the topic “Heralding the partnership in a new era.”

Mr. Moideen said that after Thumbay Group's accomplishments in the UAE, the group was expanding to Africa and the Indian subcontinent, with major projects scheduled to be completed within 2022. The launch of Thumbay Hospital, Thumbay Pharmacy, Thumbay Labs and Blends & Brews Coffee Shoppe in Hyderabad earlier this year marked the group's foray into India, and future plans include university campuses and a series of teaching hospitals in the major metros. University and hospital projects are underway in Africa as well, with the first ones expected to become operational soon. Thumbay Group has also opened representative offices in 20 different countries. Elaborating on the group's strategic plans, which includes 15 Thumbay academic hospitals in the next five years, Mr. Thumbay Moideen said, “The Thumbay academic hospital network will have a total of 1000 beds in the UAE, 1500 beds in India and 750 beds elsewhere in the Gulf and Africa, by 2022.”

About Thumbay Group

Founded by Mr. Thumbay Moideen in 1998, Thumbay Group today operates more than 20 brands across 18 different verticals including Education, Healthcare, Medical Research, Diagnostics, Retail Pharmacy, Health Communications, Retail Opticals, Wellness, Nutrition Stores, Hospitality, Real Estate, Publishing, Technology, Media, Events, Medical Tourism, Trading and Marketing & Distribution. Headquartered in Dubai, the group presently employs around 5000 people, which is projected to increase to around 20000 by the year 2022, with the completion of ongoing and upcoming projects. Currently, Thumbay Group is focusing on its strategic long-term plans which will see the group scale its businesses almost ten times and expand its operations globally.

thmby 1

thmby 3

Comments

ABDUSAMAD NANDAR
 - 
Thursday, 15 Dec 2016

masha allah tabarakallh! sir, alf alf mabrouk. with dedication and hardwork you achieved this height. may almighty shower his blessings and insha allah during coming years, we wish you will be included in the list of global business achievers.

Ahmed Bava Valavoor
 - 
Wednesday, 14 Dec 2016

Masha Alla
Congratulation Brother Mr. Moideen Thumbay all the very best may Almighty Allah bless you and all of us.

PROF.M.ABUBAKE…
 - 
Tuesday, 13 Dec 2016

Congratulations Sir. May Almighty Allah keep you rewarded for your best work. ameen May Almighty Allah give you and your family members strength and long life to do the services forever. ameen.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 28,2020

Bengaluru, Mar 28: Sun Tsu, in 'The Art of War' speaks of a skilful general who can subdue his enemy without any fighting. This constitutes the ultimate triumph which is referred to as stratagem. Today, we would need one such when we are faced with the '21-day corona challenge' for India.
Nearly four weeks back, Dr Jyothsna Rao, Dr Gururaj Rao and I sat across the OPD in the afternoon at HCG Bengaluru discussing our ongoing cancer immunology research. While on this topic, we drifted into the discussion on the coronavirus. During this engaging discussion, we wondered the similarity of the enigma between the virus and cancer. I paused to ask Dr Jyothsna and Dr Guru - how we wish we could do something against this virus.
Dr Jyothsna is a PhD from NCBS and had worked under Dr Ralph Steinman, physician and researcher from Rockefeller University, who won the Nobel Prize for his discovery of the dendritic cell and its role in adaptive immunity in 2011. Dr Gururaj is a molecular and cell biologist who did his PhD at the Chapel Hill, University of North Carolina and is the Director of iCrest.
Jyothsna while hearing our perplexing conversation on the covid intervened, "Yes, surely. I think we should take a break from cancer and focus on the innate and adaptive immunity role in COVID-19."
Thus began this sincere attempt to relook the human immune system from the eyes of the COVID-19.
We have 10 types of immune cells at the least which are widely dispersed in millions across the body. When our body is invaded by a foreign organism (bacteria, fungi or virus), these cells work with each other to destroy the invader.
Now, the question is - how do the immune cells talk to each other? They use small-molecule substances called cytokines (cyto means cells; kine means movement). There are many cytokines that are involved in work on the immune system. The most relevant for viruses are interferons.
Interferons (IFN) as the name reflects have an ability to interfere with the viral activity and stop their multiplication. These specialised signal proteins are released by our cells in response to a viral attack to forewarn other cells. They help build the antiviral proteins within the cells to kill the virus as it tries to invade the new cells.
Historically, interferons are a group of cytokines known to be potent antiviral agents against viruses and a hallmark cytokine induced by the host upon viral infections. Interferons possess unique immunoregulatory activities and are signature cytokines released by (TH1) T immune cells, which are crucial in viral infections.
As the outbreak of COVID-19 grapples us, an urgent need for finding strategies to combat the virus is growing. Coronaviruses (CoVs) are a group of RNA viruses. In patients infected with coronavirus, it was indicated that the activation of the IFN does not occur until 48 hours post-infection. Thus the delayed IFN-related antiviral response by the healthy cells leads to coronavirus evade the immune response.
Numerous studies have presented the success in defeating CoVs by the direct administration of IFNs. In a combination as a concoction, it was shown to synergistically inhibit the virus replication in vitro.
Moreover, it is understood that the earlier induction of IFNs in children although they have a less developed immune system could be the reason behind the children being least affected.
The key to success in reducing the disease fatality might be the stimulation of the immune responses to trigger IFN production at the very early stages of the disease, which might be done through the administration of IFN. Despite the evidence for the efficacy of IFNs in treating CoV-induced infections, the proper dosing and ideal timing for such interventions needs to be verified in clinical trials.
For the later stages of the diseases in advance stages where patients are on ventilator and have developed respiratory distress, we propose to utilise the mesenchymal cells derived from donor bone marrow that have been known to treat acute respiratory syndrome. Mesenchymal cells are known to possess anti-inflammatory activity and thus used often in autoimmune diseases.
With this scientific background, we have activated T cells from healthy donors, in a cGMP facility at iCrest - HCG hospital with an enriched cocktail of cytokines rich in Interferons. Injections of this cocktail we believe will result in a surge of cytokines in the body of the infected person and will boost his ability to fight the virus in the early phases. We are in the initial phases of this study and hope to be ready in the coming weeks with meaningful data on its potential utility.
Currently, it awaits government approvals (Union and state) and we have applied to central drugs authority for their initial evaluation and further directions.
As my Guru often expounded the philosophy of 'Seva' - the goal of education is knowledge, the end goal of knowledge is service. In this attempt to serve our fellow humans at this brink of unprecedented crisis, medical fraternity stands with you and promises to do our best for your safety.
We assure to exhaust every bit of our spirit in this fight against coronavirus. We have lost the sight of shores and travelled thus far, but that is the mandatory first step to cross the ocean. Are we going to succeed in this battle, is something only time will answer. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 29,2020

Mangaluru, Jan 29: Days after some youths allegedly threatened to 'behead' local MLA and former Karnataka minister U T Khader during a pro-CAA rally here, the Dakshina Kannada district unit of the Congress on Wednesday urged the police to register a case against the culprits.

A video of the incident that went viral on social media showed the youths raising slogans that they will "cut off his limbs and chop off his head if necessary" during the rally organised by the BJP in support of the Citizenship Amendment Act on Monday.

Addressing reporters here, District Congress Committee president Harish Kumar demanded that the police register a case on their own against the youths. He said if prompt action was not taken against the youths seen in the video, the Congress will launch an agitation before the office of the Commissioner of Police.

When asked by reporters about the video, Khader had on Tuesday brushed aside the threat, saying he had not taken it seriously. The MLA had also said he did not file a complaint with police as he had concern for the families of the youths.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 16,2020

Tirumala, Jul 16: As many as 14 priests of Tirumala Tirupati Devasthanams (TTD) were tested positive for COVID-19 in Andhra Pradesh on Thursday, said Anil Kumar Singhal, Executive officer, TTD.

Singhal also held a meeting with temple priests, health and vigilance officials today.

On July 14, Singhal held 'Dial your EO' programme at TTD administrative building conference hall wherein the EO addressed the devotees and media and informed that 91 TTD employees have tested positive for COVID-19 till date.

According to the Union Health Ministry, the state has reported 35,451 COVID-19 cases including, 16,621 active cases, 18,378 recovered and 452 deaths so far.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.